SIGLEC10

Sialic acid binding Ig-like lectin 10
Identifiers
Symbols SIGLEC10 ; PRO940; SIGLEC-10; SLG2
External IDs OMIM: 606091 MGI: 2443630 HomoloGene: 13228 GeneCards: SIGLEC10 Gene
Orthologs
Species Human Mouse
Entrez 89790 243958
Ensembl ENSG00000142512 ENSMUSG00000030468
UniProt Q96LC7 Q80ZE3
RefSeq (mRNA) NM_001171156 NM_172900
RefSeq (protein) NP_001164627 NP_766488
Location (UCSC) Chr 19:
51.41 – 51.42 Mb
Chr 7:
43.41 – 43.42 Mb
PubMed search

Sialic acid-binding Ig-like lectin 10 is a protein that in humans is encoded by the SIGLEC10 gene.[1][2] The mouse orthologue is Siglec G.

Structure and Function

Like most but not all other Siglecs, Siglec-10 bears an ITIM (Immunoreceptor tyrosine-based inhibitory motif) within its cytoplasmic domain. Siglec-10 is a ligand for CD52, the target of the therapeutic monoclonal antibody Alemtuzumab.[3] It is also reported to bind to Vascular adhesion protein 1 (VAP-1) and to the co-stimulatory molecule CD24 also known as HSA (Heat-stable antigen).

Gene Family summary

SIGLECs are members of the immunoglobulin superfamily that are expressed on the cell surface. Most SIGLECs have 1 or more cytoplasmic immune receptor tyrosine-based inhibitory motifs, or ITIMs. SIGLECs are typically expressed on cells of the innate immune system, with the exception of the B-cell expressed SIGLEC6 (MIM 604405).[supplied by OMIM][2]

References

  1. Munday J, Kerr S, Ni J, Cornish AL, Zhang JQ, Nicoll G, Floyd H, Mattei MG, Moore P, Liu D, Crocker PR (Apr 2001). "Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor". Biochem J 355 (Pt 2): 489–97. doi:10.1042/0264-6021:3550489. PMC 1221762. PMID 11284738.
  2. 1 2 "Entrez Gene: SIGLEC10 sialic acid binding Ig-like lectin 10".
  3. Clark, M. and A. Cooke (2013). "Regulation unmasked by activation.". Nat Immunol 14: 696–697. doi:10.1038/ni.2646.

Further reading


This article is issued from Wikipedia - version of the Wednesday, September 02, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.